Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Hans‐Peter Hobbach"'
Autor:
Martin Borlich, Uwe Zeymer, Harm Wienbergen, Hans-Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf, Werner Scholtz, Peter Lanzer, Harald Mudra, Markus Schwefer, Peter-Lothar Schwimmbeck, Christoph Liebetrau, Holger Thiele, Christoph Claas, Thomas Riemer, Ralf Zahn, Leon Iden, Gert Richardt, Ralph Toelg
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 1, Pp 89-101 (2023)
Abstract Introduction The preference for using transradial access (TRA) over transfemoral access (TFA) in patients requiring percutaneous coronary intervention (PCI) is based on evidence suggesting that TRA is associated with less bleeding and fewer
Externí odkaz:
https://doaj.org/article/f9664d75a011444aa006c451e76fe60d
Autor:
Britta Janina Wagner, Hans‐Peter Hobbach, Anastasia Janina Hobbach, Lena Katharina Hieggelke, Martin Grond, Nadejda Monsefi, Reinhard Buettner
Publikováno v:
Cancer Reports, Vol 5, Iss 5, Pp n/a-n/a (2022)
Abstract Background Embolic events play an important role in clinical everyday practice. Malignant arterial embolism is a rare nevertheless often fatal entity for cardiac, cerebral or systemic ischemia, requiring immediate diagnosis and treatment. Ca
Externí odkaz:
https://doaj.org/article/c116595fbf7741df97888af2343f86d3
Autor:
Uwe Zeymer, Ralph Toelg, Harm Wienbergen, Hans-Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf, Werner Scholtz, Peter Lanzer, Harald Mudra, Markus Schwefer, Peter-Lothar Schwimmbeck, Christoph Liebetrau, Holger Thiele, Christoph Claas, Thomas Riemer, Ralf Zahn
Publikováno v:
The American Journal of Cardiology. 189:31-37
Little is known about the efficacy and safety of rivaroxaban in patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) in clinical practice. We therefore conducted a prospective observational study to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc170383ba82e80aa3f4f060b7aab63
https://doi.org/10.1016/j.amjcard.2022.11.009
https://doi.org/10.1016/j.amjcard.2022.11.009
Autor:
Uwe Zeymer, Ralph Toelg, Harm Wienbergen, Hans-Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf, Werner Scholtz, Peter Lanzer, Harald Mudra, Markus Schwefer, Peter-Lothar Schwimmbeck, Christoph Liebetrau, Holger Thiele, Christoph Claas, Thomas Riemer, Ralf Zahn
Publikováno v:
Herz.
Little is known about current patterns of antithrombotic therapy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in clinical practice in Germany.The RIVA-PCI is a prospective, non-interventional, multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5b2cee854a6b8deea61ec450fe195e
https://pubmed.ncbi.nlm.nih.gov/35243515
https://pubmed.ncbi.nlm.nih.gov/35243515
Autor:
Hans-Peter Hobbach, Martin Grond, Nadejda Monsefi, Anastasia Janina Hobbach, Reinhard Buettner, Britta Janina Wagner, Lena Hieggelke
Publikováno v:
Cancer Reports. 5
BACKGROUND Embolic events play an important role in clinical everyday practice. Malignant arterial embolism is a rare nevertheless often fatal entity for cardiac, cerebral or systemic ischemia, requiring immediate diagnosis and treatment. CASE This i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23269eafd36d5af2824326e997c3bf3e
https://doi.org/10.1002/cnr2.1513
https://doi.org/10.1002/cnr2.1513
Autor:
Hans-Peter Hobbach, Wassillij Tscherleniak, Christel Schaeffer, C. Michael Gibson, Peter Schuster, Julia Hundertmark, Robert P. Giugliano
Publikováno v:
Journal of Thrombosis and Thrombolysis. 16:167-174
Background: Previous studies have demonstrated that impaired renal function is associated with unfavourable outcomes in patients with acute coronary syndromes and following percutaneous coronary intervention. Methods: We hypothesized that serum creat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ac0d34c989b13ff107cfd0a0b71857
https://doi.org/10.1023/b:thro.0000024055.13207.50
https://doi.org/10.1023/b:thro.0000024055.13207.50
Autor:
Christopher P. Cannon, Elliott M. Antman, David A. Morrow, Hans Peter Hobbach, Sabina A. Murphy, Eugene Braunwald, Robert P. Giugliano, Duane S. Pinto, C. Michael Gibson, Stephen D. Wiviott
Publikováno v:
Journal of the American College of Cardiology. 42(9):1535-1543
ObjectivesWe hypothesized that impaired renal function would also be associated with poorer clinical outcomes among patients with ST-segment elevation myocardial infarction (STEMI) treated with fibrinolysis.BackgroundPrevious studies have demonstrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d06375a0122cdafc4adaba696b6c30
Autor:
Hans-Peter Hobbach, Peter Schuster
Publikováno v:
Zeitschrift für Kardiologie. 92:213-218
Glycoprotein IIb/IIIa inhibitors have become the standard of care for patients undergoing percutaneous coronary intervention (PCI) and for those presenting with non-ST-segment elevation myocardial infarction (NSTE-ACS). Clinical effects of GP IIb/III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8103e988cc86288e3ab2fcbbc270b88
https://doi.org/10.1007/s00392-003-0895-6
https://doi.org/10.1007/s00392-003-0895-6
Autor:
Robert P, Giugliano, Matthew T, Roe, Robert A, Harrington, C Michael, Gibson, Uwe, Zeymer, Frans, Van de Werf, Kenneth W, Baran, Hans Peter, Hobbach, Lynn H, Woodlief, Karen L, Hannan, Sally, Greenberg, Joanne, Miller, Michael M, Kitt, John, Strony, Carolyn H, McCabe, Eugene, Braunwald, Robert M, Califf
Publikováno v:
Journal of the American College of Cardiology. 41(8)
The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI).Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::246658ea5632a9937ff5b903c032c4c1
https://pubmed.ncbi.nlm.nih.gov/12706918
https://pubmed.ncbi.nlm.nih.gov/12706918
Autor:
Maurice Buchbinder, Jorge Luna-Guerra, Hans-Peter Hobbach, Peter Schuster, Julie Logan, Charles J. Davidson
Publikováno v:
Journal of the American College of Cardiology. 59:E183
The aim of the study was to determine the safety and efficacy of a novel thermal femoral artery closure device (CardioDex; Caesarea, Israel). The device is comprised of a Nitinol anchor that is deployed via the existing introducer sheath, a battery p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076364fc75ee64cc1c909df5c65386c1
https://doi.org/10.1016/s0735-1097(12)60184-3
https://doi.org/10.1016/s0735-1097(12)60184-3